EP Patent

EP2459520A1 — Crystalline forms of fesoterodine fumarate and fesoterodine base

Assigned to Teva Pharmaceutical Works PLC · Expires 2012-06-06 · 14y expired

What this patent protects

Polymorphically pure crystalline forms of fesoterodine fumarate and fesoterodine base are described and characterized.

USPTO Abstract

Polymorphically pure crystalline forms of fesoterodine fumarate and fesoterodine base are described and characterized.

Drugs covered by this patent

Patent Metadata

Patent number: EP2459520A1
Jurisdiction: EP
Classification: —
Expires: 2012-06-06
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Works PLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.